# PREVDUO
> **NDA216903** · New Drug Application · Sponsor: AZURITY · Approved 2023-02-23
## Drug
- **FDA Application Number:** NDA216903
- **Application type:** New Drug Application
- **Brand name:** PREVDUO
- **Generic name:** NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE
- **Active ingredients:** GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Endo USA
- **First approval:** 2023-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216903)
---
*AI Analytics · CC0 1.0*